ClinicalTrials.gg
RecruitingNCT07828392Updated Oct 9, 2026

Isolated Gastrocnemius Tightness and Tactile Sensitivity

An observational study in Isolated Gastrocnemius Tightness and Healthy Adult Participants, sponsored by Nigde Omer Halisdemir University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Nigde Omer Halisdemir University · Observational

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 9, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
40
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Isolated gastrocnemius tightness is associated with various foot pathologies, particularly metatarsalgia and hallux valgus, and is also commonly observed in the general population. Limited ankle dorsiflexion, typically resulting from tightness of the gastrocnemius-soleus complex, may alter normal gait mechanics and lead to compensatory movement patterns that increase mechanical stress on the lower extremity. It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

Read the detailed description

Isolated gastrocnemius tightness has been widely studied in the adult population and is associated with various foot and ankle pathologies, such as plantar fasciitis, plantar ulcers, achilles tendinopathy, pes planus, and posterior tibial tendon dysfunction. However, no study evaluating plantar tactile sensation in individuals with isolated gastrocnemius tightness has been found in the existing literature. The findings of this study are expected to contribute to the existing literature regarding the relationship between isolated gastrocnemius tightness and plantar tactile sensation and postural control. Evaluating plantar tactile sensitivity and postural control together may help elucidate not only the mechanical effects of isolated gastrocnemius tightness on joint range of motion but also its potential effects related to sensory and postural control. This study plans to include 40 participants: 20 with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

02

Conditions studied

  • Isolated Gastrocnemius Tightness
  • Healthy Adult Participants

Keywords

  • Isolated gastrocnemius tightness
  • tactile sensitivity
  • postural control
  • foot
03

In context

Lead sponsor

Nigde Omer Halisdemir University is the lead sponsor of 93 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-65 with or without isolated gastrocnemius tightness,
  • Individuals able to walk without experiencing pain

Exclusion criteria

Exclusion Criteria:

  • Presence of neuromuscular disease,
  • Conditions affecting plantar tactile sensation, such as diabetes,
  • History of prior surgical procedures distal to the knee joint,
  • Any current or previous symptoms related to the foot or ankle region,
  • Presence of joint hypermobility,
  • Individuals who do not volunteer.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • individuals with isolated gastrocnemius tightness

    The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the ankle dorsiflexion index (ADI): •Ankle dorsiflexion index = Dorsiflexion with knee at 20° flexion - dorsiflexion with knee in full extension The threshold value of ADI ≥10°, commonly used in the literature for classifying isolated gastrocnemius tightness, will be taken into account.

    Behavioral: Ankle Dorsiflexion Index

  • individuals without isolated gastrocnemius tightness

    The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index: For individuals without isolated gastrocnemius tightness, a threshold value of \<10° for the Ankle Dorsiflexion Index will be considered.

    Behavioral: Ankle Dorsiflexion Index

Interventions

  • BehavioralAnkle Dorsiflexion Index

    First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground. Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion. The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index

06

What researchers measure

Primary outcomes

  1. Ankle dorsiflexion index

    First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground. Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion. The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the ankle dorsiflexion index.

    Time frame: 6 months

  2. Assessment of postural control

    Postural control will be assessed using a force plate (KINVENT, France). Data will be transmitted to the force plate application via a Bluetooth connection. Prior to the actual measurements, participants will be informed about the force platform and the test conditions, and a practice trial will be conducted to familiarize them with the tests. Static postural control will be assessed under three different conditions: (1) standing on both feet with eyes open, (2) standing on both feet with eyes closed, and (3) standing on one foot with eyes open. In the assessment of postural control, the primary Center of Pressure parameters-mean Center of Pressure velocity, Center of Pressure path length, and sway area-were evaluated.

    Time frame: 6 months

  3. Plantar tactile sensitivity

    Plantar tactile sensitivity will be assessed using Semmes-Weinstein monofilaments. During the assessment, participants will be positioned prone, with their feet hanging freely off the edge of the examination table and not touching any surface. The assessment will begin with the monofilament that applies the lowest force, and the procedure will progress to progressively thicker monofilaments until the participant perceives the stimulus. The lowest Semmes-Weinstein monofilament value perceived in these areas will be recorded as the plantar tactile sensation threshold. Lower perceived pressure values indicate higher tactile sensitivity in the sole of the participant's foot.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • MARINACCIO L. [Frequency and clinical and histological significance of diseases of the uterus; critical and statistical observations on biopsies]. G Clin Med. 1953 Jul;34(7):788-823. No abstract available. Undetermined Language. PubMed 13095768 ↗
  • DeBack V. We have a part to play in changing the world: a conversation with Dr Vivien DeBack. Int Nurs Rev. 2002 Dec;49(4):199-201. doi: 10.1046/j.1466-7657.2002.00150.x. No abstract available. PubMed 12492940 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Status
Enrolling by invitation→Recruiting
changed Oct 9, 2026
Sites
Nigde Omer Halisdemir University is now Recruiting
Oct 9, 2026
Start date
Sep 30, 2026→Sep 8, 2026 (actual)
Oct 9, 2026
Contact
Study contact now listed: added r•••@gmail.com · •••2082. See the current contact
Oct 9, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Nigde Omer Halisdemir University · Niğde, Turkey (Türkiye)Contact added r•••@gmail.com · •••2082
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Enrolling by invitation→Recruiting
    Nigde Omer Halisdemir University is now Recruiting
    Start date Sep 30, 2026→Sep 8, 2026 (now actual)
    Contact Study contact now listed: added r•••@gmail.com · •••2082. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Nigde Omer Halisdemir University · Niğde, Turkey (Türkiye)Contact added r•••@gmail.com · •••2082

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07828392
Lead sponsor
Nigde Omer Halisdemir University
Responsible party
Rabia ZORLULAR (Principal Investigator, Nigde Omer Halisdemir University) — Principal investigator
First posted
Sep 18, 2026
Start date
Sep 8, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Rabia ZORLULAR
Contact
rabiaeraslan118@gmail.com
+5424362082
Rabia ZORLULAR
principal investigator · Nigde Omer Halisdemir University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion